drugset / Trial / NCT00644449

A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Acute Symptoms of Chronic Bronchitis

NCT00644449

Phase 3 Completed 551 enrolled Pfizer
RandomizedParallel-groupDouble-blindTreatment

Summary

This study was performed to confirm that a single 2.0-g dose of azithromycin SR is at least as effective as 7 days of levofloxacin 500 mg/day in adults with acute exacerbation of chronic bronchitis Secondary objectives: To assess safety and the bacteriologic efficacy of both treatment regimens

Timeline

Start
2003-01
Primary completion
Completion
2004-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Azithromycin Small molecule 2 g Oral
Subject Levofloxacin Small molecule 500 mg Oral

Indications